Literature DB >> 21410073

Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.

Zhi-Qiang Zou1, Yu-Ping Ding, Bo Long, Ji-Guang Yuh, Ai-Ling Xu, Zhen-Wei Lang, Sai-Ying Zou, You-De Liu, Kun Ding, Yuan-Yuan Li.   

Abstract

BACKGROUND/AIMS: To describe the features of the Gpc-3, explore the significance and value about the role of Gpc-3 in pathological diagnosis and prognostic evaluation of hepatocellular carcinoma.
METHODOLOGY: Take an overview of Gpc-3 expression in hepatocellular carcinoma and its expression of the relationship between the clinicopathological features of hepatocellular carcinoma, analysis the expression of Gpc-3 in liver cell adenoma, heterosexual hyperplasia and hepatitis C.
RESULTS: The expression of GPC-3 has a certain amount of specificity and sensitivity in hepatocellular carcinoma.
CONCLUSIONS: Gpc-3 is not only a diagnostic and prognostic marker in hepatocellular carcinoma, but also is expected to be an ideal target for the therapy of hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21410073

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  2 in total

1.  Expression of Yes-associated protein modulates Survivin expression in primary liver malignancies.

Authors:  Haibo Bai; Mariana F Gayyed; Dora M Lam-Himlin; Alison P Klein; Suresh K Nayar; Yang Xu; Mehtab Khan; Pedram Argani; Duojia Pan; Robert A Anders
Journal:  Hum Pathol       Date:  2012-03-19       Impact factor: 3.466

2.  Investigation of potential molecular biomarkers and small molecule drugs for hepatocellular carcinoma transformed from cirrhosis.

Authors:  Feng Xie; Fang Zhu; Zaiming Lu; Zhengrong Liu; Hongyan Wang
Journal:  Oncol Lett       Date:  2016-05-24       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.